Covaxin can be modified to neutralise South African variant in 15 days: Bharat Biotech

Image Source : FILE PHOTO

COVAXIN, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

Makers of Covaxin, Bharat Biotech has said that they can modify the vaccine against coronavirus South African variant within 15 days. Bharat Biotech's developed India's own vaccine Covaxin against Covid-19 and was rolled out on January 16.

Addressing a Bio-Asia 2021 panel discussion on Monday, Bharat Biotech's CMD Dr Krishna Ella said that they can re-engineer the vaccine to neutralise the South African variant of the coronavirus within 15 provided they get access to its isolated strain from the Indian Council of Medical Research (ICMR).